Fox Chase Cancer Center Announces Agreement with VistaLink To Provide Medical Services for Cancer Patients Around the World
PHILADELPHIA (September 1, 1999) -- Fox Chase Cancer Center announced today, it has signed an agreement with VistaLink Medical Communications, Inc. in Houston, Texas to provide medical services to international patients and physicians.
VistaLink is an Internet-based telemedicine company that facilitates global patient-physician dialogue. Using a "store-forward" approach, VistaLink allows physicians in other countries to obtain second medical opinions from internationally recognized medical experts in the U.S. If a patient requires medical treatment that is unavailable in their country of origin, VistaLink facilitates the transfer of that patient to one of the 11 leading academic institutions in its network.
"Fox Chase is one of the leading cancer treatment centers in the world," said Dr. Guillermo Gutierrez, president of VistaLink. "We are proud to be able to offer its physician expertise, outstanding research and specialized facilities to our international patients and doctors."
The majority of VistaLink's clientele are oncology patients who are seeking second opinions or simply cannot find the degree of expertise in their own country that is available at a hospital like Fox Chase.
Fox Chase is ranked among the top-10 cancer centers in the nation for its outstanding cancer care according to U.S. News & World Report. As an academic center, Fox Chase doctors provide multi-disciplinary care, advanced technologies for treatment and effective clinical trials. The Center also specializes in cancer prevention including family risk assessment programs for breast, ovarian, prostate, and gastrointestinal cancers.
"We are pleased that VistaLink Medical Communications will provide our doctors a way to extend their expertise to cancer patients around the world," said Paul F. Engstrom, M.D., senior vice president of population science at Fox Chase. "Telemedicine is a cutting edge technology that will help us in our mission to ease the burden of cancer. With VistaLink's leadership and global network, we can do that."
VistaLink was established in 1996 to offer a unique delivery system of medical content combined with telemedicine services for the general public, corporations, physicians and medical centers. VistaLink's health care network presently includes more than 4,500 board-certified physicians in 80 countries.
Fox Chase Cancer Center is a member of Philadelphia International Medicine (PIM), a consortium of 10 area hospitals establishing the Greater Philadelphia area as the predominant destination for international patients seeking diagnosis, prevention and medical treatment.
Fox Chase Cancer Center is one of 36 National Cancer Institute-designated comprehensive cancer centers in the nation. Fox Chase activities include basic and clinical research; prevention, detection, and treatment of cancer; and community outreach programs.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Diana Quattrone at 215-728-7784.